136 related articles for article (PubMed ID: 30240297)
21. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
Qu X; Huang X; Yan W; Wu L; Dai K
Eur J Radiol; 2012 May; 81(5):1007-15. PubMed ID: 21354739
[TBL] [Abstract][Full Text] [Related]
22. Integration of the metabolic data of positron emission tomography in the dosimetry planning of radiosurgery with the gamma knife: early experience with brain tumors. Technical note.
Levivier M; Wikier D; Goldman S; David P; Metens T; Massager N; Gerosa M; Devriendt D; Desmedt F; Simon S; Van Houtte P; Brotchi J
J Neurosurg; 2000 Dec; 93 Suppl 3():233-8. PubMed ID: 11143256
[TBL] [Abstract][Full Text] [Related]
23. FDG-PET for management of cervical and ovarian cancer.
Havrilesky LJ; Kulasingam SL; Matchar DB; Myers ER
Gynecol Oncol; 2005 Apr; 97(1):183-91. PubMed ID: 15790456
[TBL] [Abstract][Full Text] [Related]
24. Temporal evolution of perfusion parameters in brain metastases treated with stereotactic radiosurgery: comparison of intravoxel incoherent motion and dynamic contrast enhanced MRI.
Kapadia A; Mehrabian H; Conklin J; Symons SP; Maralani PJ; Stanisz GJ; Sahgal A; Soliman H; Heyn CC
J Neurooncol; 2017 Oct; 135(1):119-127. PubMed ID: 28669014
[TBL] [Abstract][Full Text] [Related]
25. Radiation necrosis or tumor progression? A review of the radiographic modalities used in the diagnosis of cerebral radiation necrosis.
Mayo ZS; Halima A; Broughman JR; Smile TD; Tom MC; Murphy ES; Suh JH; Lo SS; Barnett GH; Wu G; Johnson S; Chao ST
J Neurooncol; 2023 Jan; 161(1):23-31. PubMed ID: 36633800
[TBL] [Abstract][Full Text] [Related]
26. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis.
Liu T; Xu JY; Xu W; Bai YR; Yan WL; Yang HL
Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):350-8. PubMed ID: 21094027
[TBL] [Abstract][Full Text] [Related]
27. A meta-analysis comparing 18F-FLT PET with 18F-FDG PET for assessment of brain tumor recurrence.
Li Z; Yu Y; Zhang H; Xu G; Chen L
Nucl Med Commun; 2015 Jul; 36(7):695-701. PubMed ID: 25768337
[TBL] [Abstract][Full Text] [Related]
28. Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis.
Lamba N; Muskens IS; DiRisio AC; Meijer L; Briceno V; Edrees H; Aslam B; Minhas S; Verhoeff JJC; Kleynen CE; Smith TR; Mekary RA; Broekman ML
Radiat Oncol; 2017 Jun; 12(1):106. PubMed ID: 28646895
[TBL] [Abstract][Full Text] [Related]
29. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH
Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531
[TBL] [Abstract][Full Text] [Related]
30. Clinical benefit of 11C methionine PET imaging as a planning modality for radiosurgery of previously irradiated recurrent brain metastases.
Momose T; Nariai T; Kawabe T; Inaji M; Tanaka Y; Watanabe S; Maehara T; Oda K; Ishii K; Ishiwata K; Yamamoto M
Clin Nucl Med; 2014 Nov; 39(11):939-43. PubMed ID: 25140562
[TBL] [Abstract][Full Text] [Related]
31. Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.
Youland RS; Pafundi DH; Brinkmann DH; Lowe VJ; Morris JM; Kemp BJ; Hunt CH; Giannini C; Parney IF; Laack NN
J Neurooncol; 2018 May; 137(3):583-591. PubMed ID: 29330751
[TBL] [Abstract][Full Text] [Related]
32. [Imaging methods used in the differential diagnosis between brain tumour relapse and radiation necrosis after stereotactic radiosurgery of brain metastases: Literature review].
Menoux I; Armspach JP; Noël G; Antoni D
Cancer Radiother; 2016 Dec; 20(8):837-845. PubMed ID: 28270324
[TBL] [Abstract][Full Text] [Related]
33. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
Wei J; Pei S; Zhu X
Oral Oncol; 2016 Jan; 52():11-7. PubMed ID: 26547126
[TBL] [Abstract][Full Text] [Related]
34. Incidence of intracranial radiation necrosis following postoperative radiation therapy for sinonasal malignancies.
Ahmad S; Le CH; Chiu AG; Chang EH
Laryngoscope; 2016 Nov; 126(11):2445-2450. PubMed ID: 27296477
[TBL] [Abstract][Full Text] [Related]
35. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic radiotherapy following surgery for brain metastasis: Predictive factors for local control and radionecrosis.
Doré M; Martin S; Delpon G; Clément K; Campion L; Thillays F
Cancer Radiother; 2017 Feb; 21(1):4-9. PubMed ID: 27955888
[TBL] [Abstract][Full Text] [Related]
37.
Tom MC; DiFilippo FP; Jones SE; Suh JH; Obuchowski NA; Smile TD; Murphy ES; Yu JS; Barnett GH; Angelov L; Mohammadi AM; Huang SS; Wu G; Johnson S; Peereboom DM; Stevens GHJ; Ahluwalia MS; Chao ST
J Neurooncol; 2023 Jul; 163(3):647-655. PubMed ID: 37341842
[TBL] [Abstract][Full Text] [Related]
38. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.
Yi CA; Lee KS; Lee HY; Kim S; Kwon OJ; Kim H; Choi JY; Kim BT; Hwang HS; Shim YM
Cancer; 2013 May; 119(10):1784-91. PubMed ID: 23423920
[TBL] [Abstract][Full Text] [Related]
39. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
[TBL] [Abstract][Full Text] [Related]
40. FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review.
Liu T; Xu W; Yan WL; Ye M; Bai YR; Huang G
Radiother Oncol; 2007 Dec; 85(3):327-35. PubMed ID: 18037523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
